Condensed Group statement of cash flows
View as excel [XLS - 34KB]
Six months ended 30 November 2016 Unaudited R'000 |
Six months ended 30 November 2015 Unaudited R’000 |
Year ended 31 May 2016 Audited R’000 |
||||||
---|---|---|---|---|---|---|---|---|
Cash generated by operations | 945 583 | 1 241 467 | 744 185 | |||||
Interest received | 25 693 | 17 460 | 42 082 | |||||
Interest paid | (65 819) | (11 716) | (48 207) | |||||
Taxation paid | (196 074) | (157 779) | (305 118) | |||||
Net cash generated from operating activities | 709 383 | 1 089 432 | 432 942 | |||||
Cash flows from investing activities | ||||||||
Acquisition of intangible assets and property, plant and equipment | (83 530) | (84 782) | (127 131) | |||||
Acquisition of subsidiaries net of cash acquired | 771 | – | – | |||||
Acquisition of associate | (7 530) | – | – | |||||
Disposal of subsidiary net of cash disposed | – | 13 219 | 13 219 | |||||
Capital contribution to Blue Label Mexico | – | (42 654) | (42 654) | |||||
Capital contribution to Oxigen Services India | – | – | (159 425) | |||||
Loan granted to Lornanox | (1 758) | (32 000) | (58 883) | |||||
Loans granted | (73 889) | (11 390) | (27 306) | |||||
Loans granted to associates | (3 401) | – | (1 620) | |||||
Settlement of contingent consideration | (49 109) | (1 631) | (1 931) | |||||
Other investing activities | 11 544 | 2 774 | 9 398 | |||||
Net cash utilised in investing activities | (206 902) | (156 464) | (396 333) | |||||
Cash flows from financing activities | ||||||||
Acquisition of treasury shares | (7 381) | (23 052) | (23 052) | |||||
Dividends paid to non-controlling interest | (6 600) | (4 000) | (4 000) | |||||
Dividends paid to equity holders of the parent | (242 823) | (209 098) | (209 098) | |||||
Other financing activities | (2 803) | – | – | |||||
Net cash utilised in financing activities | (259 607) | (236 150) | (236 150) | |||||
Net increase/(decrease) in cash and cash equivalents | 242 874 | 696 818 | (199 541) | |||||
Cash and cash equivalents at the beginning of the year | 589 027 | 788 411 | 788 411 | |||||
Exchange gains on cash and cash equivalents | (36) | (2 488) | 157 | |||||
Cash and cash equivalents at the end of the period | 831 865 | 1 482 741 | 589 027 |